Literature DB >> 16508761

Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.

Kim P C Kuypers1, Johannes G Ramaekers.   

Abstract

RATIONALE: Research concerning spatial memory in 3,4-methylenedioxymethamphetamine (MDMA) users has presented conflicting results showing either the presence or absence of spatial memory deficits. Two factors may have confounded results in abstinent users: memory task characteristics and polydrug use.
OBJECTIVES: The present study aims to assess whether a single dose of MDMA affects spatial memory performance during intoxication and withdrawal phase and whether spatial memory performance after MDMA is task dependent.
MATERIALS AND METHODS: Eighteen recreational MDMA users participated in a double-blind, placebo-controlled, three-way crossover design. They were treated with placebo, MDMA 75 mg, and methylphenidate 20 mg. Memory tests were conducted between 1.5 and 2 h (intoxication phase) and between 25.5 and 26 h (withdrawal phase) post-dosing. Two spatial memory tasks of varying complexity were used that required either storage of stimulus location alone (spatial memory task) or memory for location as well as processing of content or contextual information (change blindness task).
RESULTS: After a single dose of MDMA, the subjects made larger localization errors and responded faster compared to placebo in the simple spatial memory task during intoxication phase. Inaccuracy was not due to increased response speed, as determined by regression analysis. Performance in the change blindness task was not affected by MDMA. Methylphenidate did not affect performance on any of the tasks.
CONCLUSION: It is concluded that a single dose of MDMA impairs spatial memory for location but leaves processing of contextual information intact.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508761     DOI: 10.1007/s00213-006-0321-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Working memory deficits in current and previous users of MDMA ('ecstasy').

Authors:  M Wareing; J E Fisk; P N Murphy
Journal:  Br J Psychol       Date:  2000-05

2.  Blinks, blanks and saccades: how blind we really are for relevant visual events.

Authors:  Sascha M Dornhoefer; Pieter J A Unema; Boris M Velichkovsky
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

3.  Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.

Authors:  Antonio J Verdejo-García; Francisca López-Torrecillas; Francisco Aguilar de Arcos; Miguel Pérez-García
Journal:  Addict Behav       Date:  2005-01       Impact factor: 3.913

4.  Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').

Authors:  Michelle Wareing; John E Fisk; Philip Murphy; Catharine Montgomery
Journal:  Hum Psychopharmacol       Date:  2005-03       Impact factor: 1.672

5.  Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.

Authors:  D M Semple; K P Ebmeier; M F Glabus; R E O'Carroll; E C Johnstone
Journal:  Br J Psychiatry       Date:  1999-07       Impact factor: 9.319

6.  Cognitive performance and serotonergic function in users of ecstasy.

Authors:  R J Verkes; H J Gijsman; M S Pieters; R C Schoemaker; S de Visser; M Kuijpers; E J Pennings; D de Bruin; G Van de Wijngaart; J M Van Gerven; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

7.  Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.

Authors:  H C Fox; A C Parrott; J J Turner
Journal:  J Psychopharmacol       Date:  2001-12       Impact factor: 4.153

8.  Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

Authors:  M J Morgan
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

9.  Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

Authors:  U D McCann; A Ridenour; Y Shaham; G A Ricaurte
Journal:  Neuropsychopharmacology       Date:  1994-04       Impact factor: 7.853

10.  Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine.

Authors:  L L Morford; S L Inman-Wood; G A Gudelsky; M T Williams; C V Vorhees
Journal:  Eur J Neurosci       Date:  2002-08       Impact factor: 3.386

View more
  15 in total

1.  Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers.

Authors:  A M W Linssen; E F P M Vuurman; A Sambeth; W J Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-12-15       Impact factor: 4.530

2.  Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment.

Authors:  J H P van Wel; K P C Kuypers; E L Theunissen; W M Bosker; K Bakker; J G Ramaekers
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

3.  The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.

Authors:  Con Stough; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Keith Wesnes; Luke A Downey
Journal:  Psychopharmacology (Berl)       Date:  2011-10-22       Impact factor: 4.530

4.  Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses.

Authors:  Boris Mlinar; Gabriella Stocca; Renato Corradetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-29       Impact factor: 3.575

Review 5.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

Review 6.  The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.

Authors:  Thomas Steinkellner; Michael Freissmuth; Harald H Sitte; Therese Montgomery
Journal:  Biol Chem       Date:  2011-01       Impact factor: 3.915

7.  Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol).

Authors:  Marieke M Lansbergen; Glenn J H Dumont; Joop M A van Gerven; Jan K Buitelaar; Robbert-Jan Verkes
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

8.  Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.

Authors:  Janelle H P van Wel; Kim P C Kuypers; Eef L Theunissen; Wendy M Bosker; Katja Bakker; Johannes G Ramaekers
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

9.  Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss.

Authors:  Wendy M Bosker; Kim P C Kuypers; Silke Conen; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

10.  Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory.

Authors:  K P C Kuypers; R de la Torre; M Farre; M Pujadas; J G Ramaekers
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.